BeOne Medicines (ONC) Share-based Compensation Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 10.78% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.55% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 20.65% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 17.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.87% |
| Dec 31, 2025 | 16.57% |
| Sep 30, 2025 | 21.67% |
| Jun 30, 2025 | 22.87% |
| Mar 31, 2025 | 13.35% |
| Dec 31, 2024 | 19.53% |
| Sep 30, 2024 | 19.58% |
| Jun 30, 2024 | 26.33% |
| Mar 31, 2024 | 24.60% |
| Dec 31, 2023 | 23.39% |
| Sep 30, 2023 | 24.05% |
| Jun 30, 2023 | 31.49% |
| Mar 31, 2023 | 25.34% |
| Dec 31, 2022 | 26.78% |
| Sep 30, 2022 | 28.53% |
| Jun 30, 2022 | 35.61% |
| Mar 31, 2022 | 35.43% |
| Dec 31, 2021 | 34.39% |
| Sep 30, 2021 | 38.71% |
| Jun 30, 2021 | 51.48% |
| Mar 31, 2021 | 38.12% |
| Dec 31, 2020 | 44.30% |
| Sep 30, 2020 | 55.69% |
| Jun 30, 2020 | 85.86% |
| Mar 31, 2020 | 85.51% |
| Dec 31, 2019 | 113.37% |
| Sep 30, 2019 | 136.62% |
| Jun 30, 2019 | 193.84% |
| Mar 31, 2019 | 116.13% |
| Dec 31, 2018 | 128.77% |
| Sep 30, 2018 | 73.42% |
| Jun 30, 2018 | 173.62% |
| Mar 31, 2018 | 95.90% |